Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Research output: Contribution to journal › Article › peer-review

149 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science